Cholestasis associated with parenteral nutrition develops more commonly with hematologic malignancy than with inflammatory bowel disease.
D002779:Cholestasis / Q000209:etiology*; D003093:Colitis, Ulcerative / Q000150:complications*; D003424:Crohn Disease / Q000150:complications*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008223:Lymphoma / Q000150:complications*; D010288:Parenteral Nutrition / Q000009:adverse effects*; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*